San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at the forefront of artificial intelligence computing — and Illumina are combining their strengths to make genomic sequencing more efficient for researchers.

AI development powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference in San Francisco by announcing new partnerships focused on scaling AI models across healthcare. One of Nvidia’s new partnerships is with Mayo Clinic — the collaboration seeks to accelerate the development of pathology foundation models.